Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

May 15, 2008

District Court Decision Affirmed in U.S. Lovenox® (enoxaparin sodium) Patent Infringement Case
May 15, 2008

Landmark ATHENA Study Findings With Multaq® (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
May 13, 2008

Sanofi-aventis named One of Best Employers for Healthy Lifestyles by National Business Group on Health
May 5, 2008

New Study Confirms Dose-Accuracy of SoloSTAR® Prefilled Insulin Pen

100% of Insulin Doses Administered Were Delivered Within Pre-Determined Guidelines and Standard Dosing Limitations
May 1, 2008

Sanofi-aventis: Encouraging First-Quarter 2008 Results; Further Positive Phase III Results for Eplivanserin

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.